Can I Buy Bristol-Myers Squibb Co Shares in India?

Yes, Bristol-Myers Squibb Co shares can be bought in India by opening an international trading account with Groww.

How to Buy Bristol-Myers Squibb Co Shares in India?

One can easily invest in Bristol-Myers Squibb Co shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Bristol-Myers Squibb Co shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Bristol-Myers Squibb Co.

What is the Share Price of Bristol-Myers Squibb Co?

The share price of Bristol-Myers Squibb Co is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Bristol-Myers Squibb Co share price is $55.65 as of 13 Dec ‘24

What is the Market Cap of Bristol-Myers Squibb Co?

The Bristol-Myers Squibb Co market cap is $113.13B as of 13 Dec ‘24

What is the PE and PB ratio of Bristol-Myers Squibb Co?

The PE and PB ratio of Bristol-Myers Squibb Co is -15.6 and 6.6 as of 13 Dec ‘24

Bristol-Myers Squibb Co Share Price, BMY Stock Price Quote Today

<img alt="Bristol-Myers Squibb Co" srcSet="https://assets-netstorage.groww.in/intl-stocks/logos/BMY.png 1x, https://assets-netstorage.groww.in/intl-stocks/logos/BMY.png 2x" src="https://assets-netstorage.groww.in/intl-stocks/logos/BMY.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Bristol-Myers Squibb Co Healthcare 
$55.65
-0.63(1.12%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$56.38$56.289,405,06811,195,722
FundamentalsMarket Cap$113.13B
P/B Ratio6.6
P/E Ratio-15.6
Enterprise Value$154.99B
Div. Yield4.41%
Book Value14.25
EPS(TTM)0.94
ROENA
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyHeadquartered in 430 East 29th Street, New York City, Bristol-Myers Squibb is an American Pharmaceutical company. It is also known as BMS, and its origin dates back to 1885 when Dr Edward Robinson Squibb, opened his first laboratory in Brooklyn, New York. 
Soon after that in 1887, William Bristol and John Myers purchased the failing Clinton Pharmaceutical Company, and by 1899 it officially became Bristol-Myers Company. After the death of Dr Squibb, the company was left to his two sons in 1900. Dr Squibb aimed to provide safe and reliable medication to everyone and Bristol and Myers aimed to refrain from selling “quack remedies”.
With similar aims, the two companies collaborated for the first time in 1956 for early Cancer research. After more than three decades in 1989, the two companies officially merged to form the Bristol-Myers Squibb Company. Together, it became the world’s second-largest pharmaceutical company. Its first medicine introduced was PARAPLATIN. 
Since then it has developed an array of medicines for critical diseases, including AZACTAM, ELIQUIS, IDHIFA, BARACLUDE, OPDIVO, INREBIC, VIDAZA, etc. The company also offers its legacy products such as ATRIPLA, LYSODREN, PLAVIX, VIDEX, COUMADIN, etc. 
BMS focuses on four broad areas that are Immunoscience, Oncology, Fibrosis and Cardiovascular. It also focuses on ten drug platforms, namely Epigenetics, RNA Oligonucleotides, Antibody-Drug Conjugates, Small Molecules, Cell Therapy, Gene Therapy, Protein Homeostasis, Drug Delivery Technology, Millamolecules and Biologics. 
The company started to expand by acquiring and merging with other established businesses. Between 2009 and 2020 it acquired Medarex in 2009, ZymoGenetics in 2010, iPierian in 2014, Flexus Biosciences in 2015, Padlock Therapeutics in 2016, IFM Therapeutics in 2017 and Clegen in 2019. 
In 1998 it was awarded the National Medal of Technology by Bill Clinton for its innovative pharmaceutical research and efforts towards enhancing human life. It is the most prestigious award in the field of technological innovation in the US. 
It was back in 1929 when Bristol and Myers went public under the symbol BMY. In its trading history under the New York Stock Exchange.;
OrganisationBristol-Myers Squibb Co
IndustryDrug Manufacturers—General
HeadQuartersNew York, NY
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$56.38	$56.28	9,405,068	11,195,722

Market Cap	$113.13B
P/B Ratio	6.6
P/E Ratio	-15.6
Enterprise Value	$154.99B

Organisation	Bristol-Myers Squibb Co
Industry	Drug Manufacturers—General
HeadQuarters	New York, NY